BioSpace News Archive

Policy

Daiichi Sankyo, Inc. Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan

April 6, 2010
·
4 min read
Christian M. Spaulding, M.D., Ph.D. to Join Cordis Corporation

April 6, 2010
·
2 min read
Status Regarding Novo Nordisk A/S’s Holding Of Its Own Shares (31 March 2010)

April 6, 2010
·
1 min read
Business

Vivalis: A Solid Performance For 2009

April 6, 2010
·
15 min read
Genetown

New Approaches to R&D May Prove Best Path for Drug Developers, According to Tufts Center for the Study of Drug Development

April 6, 2010
·
3 min read
BioMidwest

Akebia Announces Participation in the Future Leaders in the Biotech Industry Conference

April 6, 2010
·
1 min read
Business

BIOLASE Technology, Inc. Announces Presentation of Its Technology to National Meeting of Eye Surgeons

April 6, 2010
·
3 min read
Biotech Bay

Facet Biotech Announces Two Presentations at American Academy of Neurology Annual Meeting

April 6, 2010
·
5 min read
Drug Development

Patient Enrollment Complete in Tragara Pharmaceuticals, Inc.'s Phase II Trial of Capoxigem(R) in Non-Small Cell Lung Cancer

April 6, 2010
·
5 min read
Business

Intrexon Division on the Move To Foster City; Appoints Richard A. Waldron and Stephen T. Worsley as Chief Financial Officer and Vice President, Business Development, Respectively

April 6, 2010
·
1 min read